title: Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.
abstract: While atrial fibrillation is common comorbidity in patients with cardiomyopathy and heart failure, diagnosis and management often focuses on tackling rate and rhythm control rather than elucidating pathogenic mechanisms related to underlying myocardial substrates. This review summarizes our current understanding of the natural history of cardiomyopathies presenting with atrial fibrillation, and the importance of managing underlying cardiomyopathic condition as diagnostic and treatment strategy for atrial fibrillation.
authors: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH, 44195, USA.
authors: Adam
authors: A
authors: Mohmand-Borkowski
authors: W H Wilson
authors: WH
authors: Tang
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D064752:Atrial Remodeling; D009202:Cardiomyopathies / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D019468:Disease Management; D055106:Genome-Wide Association Study; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology; D006334:Heart Function Tests / Q000379:methods; D006339:Heart Rate; D006801:Humans; D009154:Mutation
chemical_list: D000889:Anti-Arrhythmia Agents